Neonatal pulmonary hemorrhage

NeoReviews

Volumn 13, Issue 5, 2012, Pages

  Zahr, Riad Abou ^a   Ashfaq, Ahmad ^a   Marron Corwin, Mary ^a,b  

^a Harlem Hospital Center ^*  (United States)

^b HARLEM HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84860575330     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.13-5-e302     Document Type: Article

References (26)

1. Braun KR, Davidson KM, Henry M, Nielsen HC. Severe pulmonary hemorrhage in the premature newborn infant: analysis of presurfactant and surfactant eras. Biol Neonate. 1999;75(1): 18-30
2. Berger TM, Allred EN, Van Marter LJ. Antecedents of clinically significant pulmonary hemorrhage among newborn infants. J Perinatol. 2000;20(5):295-300
3. Cole VA, Normand IC, Reynolds EO, Rivers RP. Pathogenesis of hemorrhagic pulmonary edema and massive pulmonary hemorrhage in the newborn. Pediatrics. 1973;51(2):175-187
4. West JB, Mathieu-Costello O. Stress failure of pulmonary capillaries: role in lung and heart disease. Lancet. 1992;340 (8822):762-767
5. Amizuka T, Shimizu H, Niida Y, Ogawa Y. Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur J Pediatr. 2003;162(10):697-702
6. Mehta R, Petrova A. Intrauterine neutrophil activation is associated with pulmonary haemorrhage in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2006;91(6): F415-F418
7. Garland J, Buck R, Weinberg M. Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. Pediatrics. 1994;94(5):719-723
8. Kluckow M, Evans N. Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr. 2000;137(1):68-72
9. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344(26):1966-1972
10. Alfaleh K, Smyth JA, Roberts RS, Solimano A, Asztalos EV, Schmidt B; Trial of Indomethacin Prophylaxis in Preterms Investigators. Prevention and 18-month outcomes of serious pulmonary hemorrhage in extremely low birth weight infants: results from the trial of indomethacin prophylaxis in preterms. Pediatrics. 2008;121 (2):e233-e238
11. Stevenson D, Walther F, Long W, et al; The American Exosurf Neonatal Study Group I. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. J Pediatr. 1992;120(2 pt 2):S3-S12
12. Raju TN, Langenberg P. Pulmonary hemorrhage and exogenous surfactant therapy: a metaanalysis. J Pediatr. 1993;123(4): 603-610
13. Tomaszewska M, Stork E, Minich NM, Friedman H, Berlin S, Hack M. Pulmonary hemorrhage: clinical course and outcomes among very low-birth-weight infants. Arch Pediatr Adolesc Med. 1999;153(7):715-721
14. Cohen IJ. Room temperature ADP-induced first-stage hyperaggregation of human platelets: the cause of rewarming deaths by thrombocytopenia in neonatal cold injury. Pediatr Hematol Oncol. 1991;8(1):61-67
15. Bancalari E. The Newborn Lung. Philadelphia, PA: Saunders/ Elsevier; 2008:428
16. Piacentini E, López-Aguilar J, García-Martín C, et al. Effects of vascular flow and PEEP in a multiple hit model of lung injury in isolated perfused rabbit lungs. J Trauma. 2008;65 (1):147-153
17. AlKharfy TM. High-frequency ventilation in the management of very-low-birth-weight infants with pulmonary hemorrhage. Am J Perinatol. 2004;21(1):19-26
18. Bhandari V, Gagnon C, Rosenkrantz T, Hussain N. Pulmonary hemorrhage in neonates of early and late gestation. J Perinat Med. 1999;27(5):369-375
19. Olomu N, Kulkarni R, Manco-Johnson M. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol. 2002;22 (8):672-674
20. Cetin H, Yalaz M, Akisu M, Karapinar DY, Kavakli K, Kultursay N. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Blood Coagul Fibrinolysis. 2006;17(3):213-216
21. Holm BA, Notter RH. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity. J Appl Physiol. 1987;63(4):1434-1442
22. Pandit PB, Dunn MS, Colucci EA. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage. Pediatrics. 1995;95(1):32-36
23. Aziz A, Ohlsson A. Surfactant for pulmonary hemorrhage in neonates. Cochrane Database Syst Rev. 2008;(2):CD005254
24. Lodha A, Kamaluddeen M, Akierman A, Amin H. Role of hemocoagulase in pulmonary hemorrhage in preterm infants: a systematic review. Indian J Pediatr. 2011;78(7):838-844
25. Shi Y, Tang S, Li H, Zhao J, Pan F. New treatment of neonatal pulmonary hemorrhage with hemocoagulase in addition to mechanical ventilation. Biol Neonate. 2005;88(2):118-121
26. Shi Y, Zhao J, Tang S, et al. Effect of hemocoagulase for prevention of pulmonary hemorrhage in critical newborns on mechanical ventilation: a randomized controlled trial. Indian Pediatr. 2008;45(3):199-202